Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 3:38 pm Sale | 13G | PHARMACYTE BIOTECH INC PMCB | Ayrton Capital LLC | 956,229 9.9% | -794,483 (-45.38%) | View |
| 2024-02-06 09:56 am Sale | 13G | PHARMACYTE BIOTECH INC PMCB | INTRACOASTAL CAPITAL LLC | 903,412 9.99% | -1,015,547 (-52.92%) | View |
| 2023-11-22 4:00 pm Purchase | 13D | FEMASYS INC FEMY | PharmaCyte Biotech Inc. PMCB | 12,711,864 37% | 12,711,864 (New Position) | View |
| 2023-06-16 5:22 pm Unchanged | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 2,280,000 4.99% | 0 (Unchanged) | View |
| 2023-05-19 5:19 pm Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | Ayrton Capital LLC | 1,750,712 9.99% | 1,750,712 (New Position) | View |
| 2023-05-12 4:22 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 2,280,000 7% | 890,131 (+64.04%) | View |
| 2023-02-14 4:30 pm Sale | 13G | PHARMACYTE BIOTECH INC PMCB | Shay Capital LLC | 0 0% | -1,037,882 (Position Closed) | View |
| 2023-02-08 06:05 am Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | INTRACOASTAL CAPITAL LLC | 1,918,959 9.99% | 687,477 (+55.83%) | View |
| 2023-01-10 11:57 am Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | SABBY MANAGEMENT LLC | 934,456 11% | 673,528 (+258.13%) | View |
| 2022-10-20 10:38 am Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | Shay Capital LLC | 1,037,882 5% | 1,037,882 (New Position) | View |
| 2022-08-15 5:38 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 1,389,869 6.7% | 12,400 (+0.90%) | View |
| 2022-07-11 5:11 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 1,377,469 6.6% | 118,678 (+9.43%) | View |
| 2022-06-23 3:40 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 1,258,791 6.7% | 210,145 (+20.04%) | View |
| 2022-02-11 07:49 am Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | INTRACOASTAL CAPITAL LLC | 1,231,482 5.6% | 168,272 (+15.83%) | View |
| 2022-01-04 10:43 am Sale | 13G | PHARMACYTE BIOTECH INC PMCB | SABBY MANAGEMENT LLC | 260,928 11% | -985,317 (-79.06%) | View |
| 2021-11-04 07:38 am Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 1,048,646 5.1% | 1,048,646 (New Position) | View |
| 2021-08-30 08:30 am Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | SABBY MANAGEMENT LLC | 1,246,245 11% | 1,246,245 (New Position) | View |
| 2021-08-30 06:31 am Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | INTRACOASTAL CAPITAL LLC | 1,063,210 6.3% | 1,063,210 (New Position) | View |
| 2020-07-29 4:34 pm Sale | 13D | PHARMACYTE BIOTECH INC PMCB | Montazeri Nima | 0 0% | -95,262,015 (Position Closed) | View |
| 2020-05-06 2:19 pm Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Montazeri Nima | 95,262,015 5.8% | 95,262,015 (New Position) | View |